Latest Insider Transactions at Calyxt, Inc. (CLXT)
This section provides a real-time view of insider transactions for Calyxt, Inc. (CLXT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Calyxt, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Calyxt, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 19
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-2.19%
|
$3,450
$3.45 P/Share
|
Dec 18
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-2.14%
|
$3,450
$3.75 P/Share
|
Dec 17
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-2.1%
|
$3,450
$3.85 P/Share
|
Dec 16
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-2.05%
|
$4,600
$4.06 P/Share
|
Dec 13
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-2.01%
|
$3,450
$3.87 P/Share
|
Dec 12
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.97%
|
$4,600
$4.08 P/Share
|
Dec 11
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.93%
|
$4,600
$4.35 P/Share
|
Dec 10
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.9%
|
$4,600
$4.43 P/Share
|
Dec 09
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.86%
|
$4,600
$4.15 P/Share
|
Dec 06
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.83%
|
$3,450
$3.86 P/Share
|
Dec 05
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.8%
|
$4,600
$4.0 P/Share
|
Dec 04
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.76%
|
$4,600
$4.39 P/Share
|
Dec 03
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.73%
|
$4,600
$4.69 P/Share
|
Dec 02
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
2,300
-3.35%
|
$9,200
$4.46 P/Share
|
Nov 27
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.65%
|
$4,600
$4.5 P/Share
|
Nov 26
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.62%
|
$4,600
$4.57 P/Share
|
Nov 25
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.59%
|
$4,600
$4.19 P/Share
|
Nov 22
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.57%
|
$4,600
$4.32 P/Share
|
Nov 21
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.55%
|
$4,600
$4.03 P/Share
|
Nov 20
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.52%
|
$4,600
$4.3 P/Share
|
Nov 19
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.5%
|
$4,600
$4.12 P/Share
|
Nov 18
2024
|
Gerhard Prante Director |
SELL
Open market or private sale
|
Direct |
1,150
-1.48%
|
$4,600
$4.53 P/Share
|
Nov 12
2024
|
Carlo Broos Interim CFO |
SELL
Open market or private sale
|
Direct |
4,647
-5.89%
|
$23,235
$5.3 P/Share
|
Nov 11
2024
|
Carlo Broos Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+20.64%
|
$102,500
$5.75 P/Share
|
Sep 18
2024
|
Rory B Riggs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+6.75%
|
$1,000,000
$4.0 P/Share
|
Jul 15
2024
|
Gregory Francis William Gocal Chief Scientific Officer & EVP |
SELL
Open market or private sale
|
Direct |
2,000
-0.63%
|
$20,000
$10.01 P/Share
|
Jul 12
2024
|
Gregory Francis William Gocal Chief Scientific Officer & EVP |
SELL
Open market or private sale
|
Direct |
2,000
-0.63%
|
$20,000
$10.0 P/Share
|
Jun 27
2024
|
Gregory Francis William Gocal Chief Scientific Officer & EVP |
SELL
Open market or private sale
|
Direct |
2,000
-0.62%
|
$20,000
$10.0 P/Share
|
Jun 11
2024
|
Rory B Riggs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
98,040
+2.97%
|
$980,400
$10.2 P/Share
|
May 30
2024
|
Gerhard Prante Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,072
+7.23%
|
-
|
Dec 29
2023
|
Rory B Riggs Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
1,500,000
+32.58%
|
-
|
Dec 29
2023
|
Rory B Riggs Chief Executive Officer |
SELL
Conversion of derivative security
|
Direct |
1,500,000
-52.32%
|
-
|
Dec 29
2023
|
Rory B Riggs Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
1,505,967
+34.44%
|
-
|
Dec 12
2023
|
Rory B Riggs Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
517,107
+24.17%
|
$5,171,070
$10.58 P/Share
|
Sep 27
2023
|
Rory B Riggs Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
39,476
-3.45%
|
-
|
Jun 01
2023
|
Rory B Riggs Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.09%
|
$31,000
$31.5 P/Share
|
May 31
2023
|
Jonathan Finn > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
1,518,015
+25.39%
|
-
|
May 31
2023
|
Jonathan Finn > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
1,276,247
+19.87%
|
-
|
May 31
2023
|
Jonathan Finn > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
1,206
+50.0%
|
-
|
May 31
2023
|
William Koschak Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,333
+24.51%
|
-
|
May 31
2023
|
Debra H Frimerman General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,533
+22.76%
|
-
|
May 31
2023
|
Travis Frey Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,733
+23.12%
|
-
|
May 31
2023
|
Michael A. Carr President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,533
+31.89%
|
-
|
May 31
2023
|
Gerhard Prante Director |
BUY
Grant, award, or other acquisition
|
Direct |
71,785
+50.0%
|
-
|
May 31
2023
|
Gregory Francis William Gocal Chief Scientific Officer & EVP |
BUY
Grant, award, or other acquisition
|
Direct |
320,844
+34.83%
|
-
|
May 31
2023
|
Jean Pierre Jules Lehmann Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,687,071
+50.0%
|
-
|
May 31
2023
|
Peter Beetham Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,503
+50.0%
|
-
|
May 31
2023
|
Peter Beetham Director |
BUY
Grant, award, or other acquisition
|
Direct |
378,934
+34.39%
|
-
|
May 31
2023
|
Mark Terrence Finn Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,348
+50.0%
|
-
|
May 31
2023
|
Mark Terrence Finn Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,143,949
+48.61%
|
-
|